These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23778885)
1. Phosphorylation of cMet tyrosine residues in murine ascitic hepatic cancer cell lines with different lymph node metastatic potentials. Li Y; Huang X; Zhang Q; Ma K Mol Med Rep; 2013 Aug; 8(2):655-61. PubMed ID: 23778885 [TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM3 inhibits hepatoma cell motility via down-regulating activity of EGFR and PI3K/AKT signaling pathway. Huang X; Li Y; Zhang J; Xu Y; Tian Y; Ma K J Cell Biochem; 2013 Jul; 114(7):1616-24. PubMed ID: 23355442 [TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway. Li Y; Huang X; Zhang J; Li Y; Ma K Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914 [TBL] [Abstract][Full Text] [Related]
4. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling. Li Y; Huang X; Zhong W; Zhang J; Ma K Mol Cell Biochem; 2013 Oct; 382(1-2):83-92. PubMed ID: 23749170 [TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018 [TBL] [Abstract][Full Text] [Related]
6. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2. Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339 [TBL] [Abstract][Full Text] [Related]
7. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells. Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991 [TBL] [Abstract][Full Text] [Related]
8. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells. Shi MD; Liao YC; Shih YW; Tsai LY Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747 [TBL] [Abstract][Full Text] [Related]
9. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723 [TBL] [Abstract][Full Text] [Related]
10. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells. Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476 [TBL] [Abstract][Full Text] [Related]
11. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity. Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768 [TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233 [TBL] [Abstract][Full Text] [Related]
13. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells. Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
15. [Effects of lipid rafts on signal transmembrane transduction mediated by c-Met]. Wang L; Zhao YF; Li YL; Xu YF; Xia Q; Ma KL Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):449-52. PubMed ID: 18578997 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor signal coupling to various transcription factors depends on triggering of Met receptor and protein kinase transducers in human hepatoma cells HepG2. Tacchini L; Dansi P; Matteucci E; Desiderio MA Exp Cell Res; 2000 Apr; 256(1):272-81. PubMed ID: 10739674 [TBL] [Abstract][Full Text] [Related]
20. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]